BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Another Good Day for Amgen as Repatha Phase III GLAGOV Trial Met Primary, Secondary Endpoints

  September 20, 2016

   · 

  2 min read
• 

  Business

  Continuing Its String of Deals, Allergan Buys Bay Area’s Tobira for $1.695 Billion

  September 20, 2016

   · 

  3 min read
• 

  Business

  Drumroll, Please...GlaxoSmithKline Just Named This Woman Its New CEO

  September 20, 2016

   · 

  2 min read
• Policy

  $90 Billion Whistleblower Suit Filed Against Four Of The Nation’s Largest Chemical Companies

  September 20, 2016

   · 

  1 min read
• Biotech Bay

  Glyphosate Herbicide In Vaccines? Here Is What Frightened Parents Should Know

  September 20, 2016

   · 

  1 min read
• BioCapital

  If You Were At Higher Risk Of Developing Dementia, Would You Want To Know?

  September 20, 2016

   · 

  1 min read
• New Knowledge About Mitochondrial Proteins May Improve Disease Diagnostics

  September 20, 2016

   · 

  1 min read
• Policy

  The Man Who Started EpiPen’s Price Rise Won’t Face Congress

  September 20, 2016

   · 

  1 min read
• Biotech Bay

  Will The “Femtech” Revolution Really Offer A “Digital Contraceptive” And Detect Diseases Through A Phone?

  September 20, 2016

   · 

  1 min read
• Maggots Being Used As Medical Devices

  September 20, 2016

   · 

  1 min read